Effect of a nutritional support system (diet and supplements) for improving gross motor function in cerebral palsy: An exploratory randomized controlled clinical trial
- Fernando Leal-Martínez,
- Denise Franco,
- Andrea Peña-Ruiz,
- Fabiola Castro-Silva,
- Andrea A. Escudero-Espinosa,
- Oscar G. Rolón-Lacarrier
- Universidad Anáhuac,
- Centro de Rehabilitación e Inclusión Infantil Teletón (CRIT),
- Instituto Mexicano del Seguro Social,
- ,
Open access
Publication Information
Output type
Original language
EnglishArticle number
1449Journal (Volume, Issue Number)
Foods (Volume 9, Issue 10)Publication milestones
- Published - 13/10/2020
Publication status
Publication IDs
- Scopus: 85092629804
Abstract
Background: Most patients with cerebral palsy (CP) do not respond to physical therapy due to deterioration in their nutritional status, secondary to gastrointestinal disorders and the catabolic state of the disease itself. However, basic treatments only contemplate the energy requirements and do not consider supplementation with glutamine, zinc, selenium, colecalciferol, spirulina, omega 3 or even vegetal proteins. Objective: In this study, we determined the effect of using a nutritional support system (NSS): diet and supplements, on the gross motor function in children with CP with spastic diparesic and Gross Motor Function Classification System III (GMFCS III). Methods: An exploratory study was performed. Thirty patients (from 4 to 12 years old) were randomly assigned to: (1) dietary surveillance (FG), (2) deworming and WHO diet (CG), or (3) deworming and the NSS (IG). Gross motor function was evaluated using the gross motor function measure (GMFM) scale. Results: The IG-treated group presented a significant improvement in standing and walking parameters analyzed in the GMFM compared with FG and CG groups. Fifty percent of the IG-treated patients managed to walk, while in the other groups, no patients were able to walk. Conclusions: The NSS used in the present work improves gross motor function and promotes walking in patients with CP.
